ES2175419T3 - Preparacion farmaceutica que contiene nimesulida para uso topico. - Google Patents

Preparacion farmaceutica que contiene nimesulida para uso topico.

Info

Publication number
ES2175419T3
ES2175419T3 ES97927313T ES97927313T ES2175419T3 ES 2175419 T3 ES2175419 T3 ES 2175419T3 ES 97927313 T ES97927313 T ES 97927313T ES 97927313 T ES97927313 T ES 97927313T ES 2175419 T3 ES2175419 T3 ES 2175419T3
Authority
ES
Spain
Prior art keywords
pharmaceutical preparation
nimesulide
topical use
preparation containing
containing nimesulide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97927313T
Other languages
English (en)
Inventor
Paolo Luca Maria Giorgetti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Errekappa Eurotherapici SpA
Original Assignee
Errekappa Eurotherapici SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Errekappa Eurotherapici SpA filed Critical Errekappa Eurotherapici SpA
Application granted granted Critical
Publication of ES2175419T3 publication Critical patent/ES2175419T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

PREPARADO FARMACEUTICO PARA USO TOPICO QUE CONTIENE COMO PRINCIPIO ACTIVO NIMESULIDE (CAS NO 51 803 - 78 - 2) O UNO DE SUS DERIVADOS ACTIVOS. LA PRESENTE INVENCION SE CARACTERIZA PORQUE LA BASE DE DICHO PREPARADO CONTIENE AL MENOS UN FOSFOLIPIDO Y AL MENOS UNA SUSTANCIA DE REACCION ACIDA, Y ESPECIFICAMENTE UN ACIDO. LA FIGURA MUESTRA LOS RESULTADOS DE UNA PRUEBA DE ABSORCION DE NIMESULIDE EX VIVO EFECTUADA CON AYUDA DE FORMULACIONES PARA APLICACION TOPICA INCLUYENDO LAS QUE CONSTITUYEN EL OBJETO DE LA PRESENTE INVENCION.
ES97927313T 1996-07-05 1997-07-02 Preparacion farmaceutica que contiene nimesulida para uso topico. Expired - Lifetime ES2175419T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT96RM000480A IT1291278B1 (it) 1996-07-05 1996-07-05 Preparazione farmaceutica a base di nimesulide per uso topico

Publications (1)

Publication Number Publication Date
ES2175419T3 true ES2175419T3 (es) 2002-11-16

Family

ID=11404325

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97927313T Expired - Lifetime ES2175419T3 (es) 1996-07-05 1997-07-02 Preparacion farmaceutica que contiene nimesulida para uso topico.

Country Status (13)

Country Link
US (1) US5998480A (es)
EP (1) EP0853476B1 (es)
JP (1) JPH11512116A (es)
KR (1) KR19990044280A (es)
CN (1) CN1199335A (es)
AT (1) ATE215367T1 (es)
CA (1) CA2231118C (es)
DE (1) DE69711588T2 (es)
DK (1) DK0853476T5 (es)
ES (1) ES2175419T3 (es)
IT (1) IT1291278B1 (es)
PT (1) PT853476E (es)
WO (1) WO1998001124A2 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1289973B1 (it) 1997-02-25 1998-10-19 Helsinn Healthcare Sa Sistemi gelificati di nimesulide per uso topico
IT1291895B1 (it) 1997-04-24 1999-01-21 Errekappa Euroterapici S P A Preparazione farmaceutica fluida a base di nimesulide per uso orale e rinofaringeo
WO2000072884A1 (en) * 1999-05-31 2000-12-07 Dinesh Shantilal Patel A novel formulation of n-(4-nitro-2-phenoxyphenyl)methanesulfonamide
EP1172101A1 (en) * 2000-06-20 2002-01-16 Helsinn Healthcare S.A. The use of nimesulide for the treatment of psoriasis and psoriatic arthritis
IT1318588B1 (it) * 2000-06-20 2003-08-27 Helsinn Healthcare Sa Uso della nimesulide nel trattamento di patologie dermatologiche.
KR100752990B1 (ko) * 2006-08-02 2007-08-30 주식회사 대웅 나노리포좀 및 천연 추출물을 포함하는 피부 질환의 예방또는 치료용 조성물
TR200906775A1 (tr) * 2009-09-02 2011-03-21 Sanovel İlaç San.Ve Ti̇c.A.Ş. Nimesulid ve kas gevşetici kombinasyonları
WO2014125085A1 (en) 2013-02-15 2014-08-21 Sanovel Ilac Sanayi Ve Ticaret A.S. Oral pharmaceutical formulations comprising nimesulide and thiocolchicoside

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR206496A1 (es) * 1972-07-03 1976-07-30 Riker Laboratories Inc Procedimiento para la preparacion de 2-fenoxi-4-nitro-alquil o haloalquilsulfonanilidas
US4933172A (en) * 1988-10-06 1990-06-12 Warner-Lambert Co. Method of and compositions for treating destructive periodontal disease
WO1991000043A1 (en) * 1989-06-28 1991-01-10 Black & Decker Inc. Toaster
ES2023552A6 (es) * 1990-05-22 1992-01-16 Leetrim Limited Procedimiento para la preparacion de compuestos de inclusion de nimesulida con ciclodextrina.
IT1251838B (it) * 1991-09-20 1995-05-26 Lpb Ist Farm Uso della nimesulide nel trattamento della cataratta
IL106035A0 (en) * 1992-06-24 1993-10-20 Skyview Cooling Co Pest eradicating composition and methods for reducing pests on growing plants utilizing the same
DE69529994T2 (de) * 1994-09-27 2003-12-11 Rijksuniversiteit Leiden, Leiden Phospholipid-und cholesterolfreie wässrige mittel zur topischen anwendung auf der haut
DE782855T1 (de) * 1994-10-05 1998-05-28 Helsinn Healthcare Sa Antiinflammatorische wirkstoffe zur aüsserlichen anwendung
US5763422A (en) * 1995-01-27 1998-06-09 Board Of Regents, The University Of Texas System Methods of enhancing the therapeutic activity of NSAIDS and compositions of zwitterionic phospholipids useful therein
US5654337A (en) * 1995-03-24 1997-08-05 II William Scott Snyder Topical formulation for local delivery of a pharmaceutically active agent
HUP9601442A3 (en) * 1995-07-25 1999-03-29 Panacea Biotec Ltd Nes antinflammatory and analgetic pharmaceutical compositions, containing nimesulid for transdermal use, and process for producing them
US5814659A (en) * 1996-04-23 1998-09-29 Dtr Dermal Therapy (Barbados) Inc. Topical analgesic composition
HUP9601443A3 (en) * 1996-05-29 1999-03-29 Panacea Biotec Ltd Injectable analgetic pharmaceutical compositions for intramuscular use containing nimesulid, and process for producing them
US5837289A (en) * 1996-07-23 1998-11-17 Grasela; John C. Transdermal delivery of medications using a combination of penetration enhancers
IT1286496B1 (it) * 1996-11-20 1998-07-15 Leetrim Ltd Dublin Composizione farmaceutica orale ad attivita' antipiretica,analgesica ed antiinfiammatoria

Also Published As

Publication number Publication date
ITRM960480A1 (it) 1998-01-05
US5998480A (en) 1999-12-07
EP0853476B1 (en) 2002-04-03
KR19990044280A (ko) 1999-06-25
DE69711588D1 (de) 2002-05-08
DK0853476T5 (da) 2002-10-07
CA2231118C (en) 2001-09-18
JPH11512116A (ja) 1999-10-19
PT853476E (pt) 2002-08-30
ITRM960480A0 (es) 1996-07-05
CN1199335A (zh) 1998-11-18
EP0853476A2 (en) 1998-07-22
ATE215367T1 (de) 2002-04-15
CA2231118A1 (en) 1998-01-15
WO1998001124A3 (en) 1998-02-19
DE69711588T2 (de) 2002-10-31
WO1998001124A2 (en) 1998-01-15
IT1291278B1 (it) 1999-01-07
DK0853476T3 (da) 2002-07-29

Similar Documents

Publication Publication Date Title
ES2179910T3 (es) Modificacion cristalina del cdch, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen.
ES2161085T3 (es) Formulaciones que contienen oxaliplatino.
PA8461301A1 (es) Agonistas de prostaglandinas
ES2055860T3 (es) Derivados 2-aminopirimidinona.
BR0215052A (pt) Composições acaricidas e métodos
ES2100151T3 (es) Nuevos derivados de benzopirano, procedimientos para su preparacion y su uso y composiciones que contienen los compuestos.
ES2126766T3 (es) 7-azaindol-3-ilcarboxiamidas de tropilo como agente antitusivo.
UY27740A1 (es) Nuevos compuestos
ES2052603T3 (es) Derivados de bencimidazol, procedimiento para su produccion y composicion farmaceutica que los contienen.
ES2186015T3 (es) Derivados de 2-(purin-9-il)-tetrahidrofuran-3,4-diol.
AR003938A1 (es) Compuestos triciclicos de urea utiles para la inhibicion de la funcion de la proteina g y para tratamiento de enfermedades proteoliticas, composicionfarmaceutica, y el uso de los mismos para la preparacion de medicamentos.
UY23801A1 (es) Formulacion lista acuosa, monofasica, estable para sustancias activas fitosanitarias y un procedimiento para su obtencion
AR023727A1 (es) Compuestos empleados en el tratamiento de padecimientos inflamatorios
ES2147739T3 (es) Fosfonooximetil-eteres de derivados de taxano.
AR019503A1 (es) Utilizacion de derivados sustituidos en 3 del estilbeno como agentes activos desodorantes en las composiciones cosmeticas
ES2182161T3 (es) Utilizacion de derivados de pirimidina para la preparacion de un medicamento para la prevencion del cancer.
ES2183180T3 (es) Nuevos derivados de guanidina, procedimientos para su preparacion y su uso como medicamento.
ES2194935T3 (es) Preparados estables de transglutaminasa y procedimiento para su preparacion.
ES2129485T3 (es) Derivados de acidos guanidinoalquil-1,1-bisfosfonicos, procedimiento para su preparacion y su utilizacion.
ES2067874T3 (es) Derivados de acetamida.
BR0111678A (pt) Composições medicinais contendo derivados de propenona
ES2175419T3 (es) Preparacion farmaceutica que contiene nimesulida para uso topico.
ES2076595T3 (es) Derivados de amidinofenilalanina, procedimiento para su preparacion, su empleo y agentes que los contienen.
UY24738A1 (es) Microesferas farmacéuticas de ácido valproico para administración oral
AR004474A1 (es) Compuestos de 10-aminoalifatil-dibenz [b,f]oxepinas antineurodegenerativamente activas, utiles para el tratamiento de estados neurodegenerativos y composiciones farmaceuticas que los contienen

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 853476

Country of ref document: ES